SVI Expands Commercial Leadership Ahead of
Upcoming Product Launches
SILICON VALLEY, Calif.,
July 2,
2024 /PRNewswire/ -- Silicon Valley Innovations
(SVI), a leader in clinical consumer care innovation, today
announces Howard Palefsky has joined
their board of directors as the company prepares its extensive line
of personal care products for commercialization. The company's
substantive portfolio is based upon a drug delivery platform
developed around a novel concept, marking a new era of
clinical-to-consumer healthcare technology.
![Silicon Valley Innovations, Inc. Silicon Valley Innovations, Inc.](https://mma.prnewswire.com/media/2452476/Silicon_Valley_Innovations.jpg)
SVI's innovation has resulted in the development of a
first-in-class technology centered around their highly specialized,
clinically designed applicators (Class 1, FDA-registered and
patented medical devices) for local drug delivery into specific
anatomic locations. When used in conjunction with
physician-formulated gels, the devices bring value spanning the
patient care continuum – from cleansing, to moisturizing, to the
delivery of prescription medications. It uniquely allows
medications to be optimized for local treatment in order to be more
effective and decrease systemic (whole body) reactions and/or side
effects.
Mr. Palefsky is a successful businessman from the biomedical
technology industry, with a 19+ year tenure at Collagen Corp.,
ultimately leading the company to a successful acquisition by
Inamed/Allergan. His deep and unique commercial understanding of
the MedTech industry will be critical as SVI furthers its mission
to bridge the gap between consumer and healthcare technology.
"Following the introduction of our first product and the
feedback we've received since, there's no doubt that we've created
an exciting new platform for drug delivery. We're focused on
embracing the magnitude of what we've developed, bringing that to
fruition, and growing the company to its full potential," said SVI
CEO and Founder Dr. Gail Lebovic.
"Partnering with a visionary like Howard, given his experience and
knowledge in business, as well as in medicine, is a huge win for
us. We know we're on to something big, and Howard can help guide
and accelerate our success."
SVI's Flagship Release: NasoClenz
In 2023, SVI began a
limited release of its flagship product, NasoClenz, a nasal
cleansing kit featuring the debut of SVI's innovative intranasal
device. Early clinical studies show the product has an impressive
impact on patients. A study presented at the Combined
Otolaryngology Spring Meeting in Boston, revealed that severe allergy sufferers
experienced an 84% reduction in frequent and severe nasal
symptoms. The initial success of NasoClenz swiftly opened the
door for SVI with an impressive rolling 4-quarter average sales
growth over 200%. The company's initial focus for its products is
on two major anatomic sites, each with large target markets:
Respiratory health (~$71B) and
Feminine health (~$21B).
Silicon Valley Innovations was founded in 2020, at the height of
the pandemic, hence the focus on their first product - NasoClenz –
was particularly relevant and timely. In the United States alone, over 155M individuals seek over-the-counter nasal
relief products, but beyond that, a focus on being more proactive
about healthcare and wellbeing has captured the attention of
consumers globally. The team at SVI, led by Dr. Lebovic and with
the new addition of Howard Palefsky,
is uniquely positioned to spearhead this new category of clinically
relevant products into the limelight of consumer healthcare.
"I've had the pleasure of working with Dr. Lebovic many times
throughout our careers and I am equally looking forward to this
partnership with SVI," said Palefsky. "Over my years and various
experiences in the medical industry, Dr. Lebovic continues to stand
out as a leading inventor who is particularly unique. She is
practical and truly understands real-life problems that need
clinical solutions. I see this blueprint for success not only with
NasoClenz, but with Dr. Lebovic's plan to expand the use cases of
SVI's drug delivery platform into women's health as well."
Palefsky went on to comment, "At first blush, it may seem odd to
address these two distinctly different market segments, however,
SVI's unique applicators leverage the opportunities in each of
these anatomic sites with the potential for a tremendous impact in
both the consumer and clinical spaces, making this a truly unique
and interesting business opportunity."
To stay up to date on news from Silicon Valley Innovations, Inc.
and learn more about NasoClenz, please visit:
https://svi-inc.com/.
About Howard
Palefsky
Howard
Palefsky is a veteran businessman in Silicon Valley and is
globally respected as an insightful Board Member, Executive, and
Investor. His outstanding, long, and hearty successful track record
in the life sciences, healthcare, and medical technology industries
makes him specifically well-suited for joining the Board of
Directors at SVI. He has led life-science and medical technology
organizations through significant growth, creating value exceeding
$4B. He has sat on the boards of more
than 30 organizations and has played a pivotal role in establishing
more than 20 businesses, spearheading numerous capital raises,
Initial Public Offerings, and acquisitions. Moreover, he has
overseen more than 40 new product launches across the US,
Europe, LATAM, and Asia Pacific, gaining invaluable strategic
insight into regulatory affairs and reimbursement mechanics across
multiple geographies.
About Silicon Valley Innovations
Silicon Valley
Innovations' mission is to create technological solutions that help
people lead happier, healthier lives. The company was founded by
Dr. Gail Lebovic, one of Silicon
Valley's most successful women entrepreneurs, having founded or
co-founded multiple medical technology companies with innovations
that have become standard of care and are currently marketed by
leading healthcare companies. Dr. Lebovic, a world-renowned
Oncoplastic surgeon and internationally recognized expert in
surgical options for cancer, brings more than three decades of
experience in the medical device industry to the table. Dr. Lebovic
and her team are committed to creating unique devices that solve
significant health problems and improve lives. To learn more about
Silicon Valley Innovations, visit svi-inc.com.
![Long time Medical technology CEO and Investor, Howard Palefsky, joins the Board of Silicon Valley Innovations Long time Medical technology CEO and Investor, Howard Palefsky, joins the Board of Silicon Valley Innovations](https://mma.prnewswire.com/media/2452477/Silicon_Valley_Innovations_Howard_Palefsky.jpg)
View original content to download
multimedia:https://www.prnewswire.com/news-releases/silicon-valley-innovations-inc-appoints-medtech-veteran-howard-palefsky-to-board-of-directors-302187650.html
SOURCE Silicon Valley Innovations